Total Payments
$17,388
2022 Payments
$20.97
Companies
23
Transactions
219
Medicare Patients
7,629
Medicare Billing
$750,823
Payment Breakdown by Category
Other$12,200 (70.2%)
Food & Beverage$4,121 (23.7%)
Education$567.36 (3.3%)
Consulting$500.00 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,200 | 5 | 70.2% |
| Food and Beverage | $4,121 | 198 | 23.7% |
| Education | $567.36 | 14 | 3.3% |
| Consulting Fee | $500.00 | 2 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12,055 | 20 | $0 (2021) |
| PFIZER INC. | $1,576 | 29 | $0 (2020) |
| Amgen Inc. | $645.52 | 25 | $0 (2020) |
| Esperion Therapeutics, Inc. | $518.00 | 11 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $489.75 | 32 | $0 (2020) |
| Gilead Sciences, Inc. | $368.54 | 19 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $346.72 | 17 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $263.73 | 15 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $262.92 | 14 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $147.09 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $20.97 | 1 | Bardy Diagnostics, Inc. ($20.97) |
| 2021 | $60.58 | 3 | E.R. Squibb & Sons, L.L.C. ($45.83) |
| 2020 | $736.18 | 22 | Esperion Therapeutics, Inc. ($518.00) |
| 2019 | $642.89 | 28 | Amgen Inc. ($158.20) |
| 2018 | $6,820 | 47 | E.R. Squibb & Sons, L.L.C. ($6,035) |
| 2017 | $9,107 | 118 | E.R. Squibb & Sons, L.L.C. ($5,974) |
All Payment Transactions
219 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/13/2022 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 11/18/2021 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 09/21/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.55 | General |
| Category: Cardiovascular | ||||||
| 05/11/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.28 | General |
| Category: Cardiovascular | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $51.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $51.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $51.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $51.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $51.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $51.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $49.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $48.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $40.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $40.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/25/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Education | In-kind items and services | $35.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $38.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2020 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/14/2020 | CathWorks, Inc. | FFRangio System (Device) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Cardiology | ||||||
| 07/12/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/26/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Cardiology | ||||||
| 02/19/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiology | ||||||
| 02/05/2020 | CathWorks, Inc. | FFRangio System (Device) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Cardiology | ||||||
| 01/29/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/27/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,006 | 2,612 | $873,658 | $203,181 |
| 2022 | 27 | 2,065 | 2,829 | $860,469 | $211,666 |
| 2021 | 25 | 1,755 | 2,381 | $709,844 | $186,978 |
| 2020 | 24 | 1,803 | 2,305 | $636,440 | $148,997 |
Total Patients
7,629
Total Services
10,127
Medicare Billing
$750,823
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 327 | 557 | $202,748 | $61,209 | 30.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 133 | 135 | $119,070 | $25,555 | 21.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 35 | 35 | $89,775 | $16,465 | 18.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 108 | $39,420 | $11,741 | 29.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 186 | 188 | $46,624 | $10,170 | 21.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 68 | $47,872 | $10,091 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 135 | $34,020 | $9,708 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 112 | $27,664 | $9,073 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $31,578 | $8,661 | 27.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 29 | 29 | $29,377 | $6,741 | 22.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 35 | 70 | $32,550 | $5,286 | 16.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 32 | 125 | $18,750 | $5,265 | 28.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 336 | 394 | $32,702 | $5,031 | 15.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $12,906 | $3,224 | 25.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 19 | 32 | $9,568 | $2,305 | 24.1% |
| 76376 | 3d radiographic procedure | Office | 2023 | 77 | 80 | $26,800 | $1,985 | 7.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 32 | 32 | $6,592 | $1,692 | 25.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 135 | 169 | $8,450 | $1,236 | 14.6% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 16 | 17 | $11,798 | $1,186 | 10.1% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 17 | 32 | $5,376 | $1,151 | 21.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 11 | 11 | $16,137 | $1,089 | 6.8% |
| 93784 | Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | Office | 2023 | 25 | 25 | $8,800 | $1,005 | 11.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 32 | 32 | $3,168 | $819.20 | 25.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 24 | 24 | $2,424 | $554.51 | 22.9% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 13 | 14 | $2,618 | $546.70 | 20.9% |
About Dr. Devan Marar, M.D
Dr. Devan Marar, M.D is a Cardiovascular Disease healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2009. The National Provider Identifier (NPI) number assigned to this provider is 1114152717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devan Marar, M.D has received a total of $17,388 in payments from pharmaceutical and medical device companies, with $20.97 received in 2022. These payments were reported across 219 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,200).
As a Medicare-enrolled provider, Marar has provided services to 7,629 Medicare beneficiaries, totaling 10,127 services with total Medicare billing of $750,823. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Francisco, CA
- Active Since 05/27/2009
- Last Updated 07/19/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1114152717
Products in Payments
- ELIQUIS (Drug) $13,591
- NEXLETOL (Drug) $518.00
- XARELTO (Drug) $471.66
- ENTRESTO (Drug) $346.72
- Repatha (Biological) $325.89
- Corlanor (Drug) $319.63
- LifeVest (Device) $262.92
- PRADAXA (Drug) $165.20
- Adempas (Drug) $147.09
- MULTAQ (Drug) $119.56
- BRILINTA (Drug) $108.71
- PRALUENT ALIROCUMAB INJECTION (Biological) $104.56
- OPSUMIT MACITENTAN (Drug) $101.39
- JARDIANCE (Drug) $98.53
- ZIO Patch (Device) $48.57
- FFRangio System (Device) $46.94
- CHANTIX (Drug) $40.02
- Veltassa (Drug) $39.63
- Carnation Ambulatory Monitor (Device) $35.72
- PRALUENT (Drug) $22.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Francisco
Dr. Philip Sager, Md, MD
Cardiovascular Disease — Payments: $851,687
Cardiovascular Disease $851,687
Dr. Melvin Scheinman, M.d, M.D
Cardiovascular Disease — Payments: $315,387
Cardiovascular Disease $315,387
Dr. Henry Hsia, Md, MD
Cardiovascular Disease — Payments: $296,299
Cardiovascular Disease $296,299
Edward Gerstenfeld, Md, MD
Cardiovascular Disease — Payments: $198,638
Cardiovascular Disease $198,638
Dr. Lloyd Klein, Md, MD
Cardiovascular Disease — Payments: $176,194
Cardiovascular Disease $176,194
Robert Gillespie, M.d, M.D
Cardiovascular Disease — Payments: $116,323
Cardiovascular Disease $116,323